Malaria
📧 Sign up to get email alerts when something new happens for Malaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Uncomplicated Malaria in South Kivu, DR Congo [Phase 4]
Phase 4 trial conducted in South Kivu, DR Congo evaluates the efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicat…
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Hati Salama (Secure Voucher) [NA]
This update notes that the malaria-focused clinical trial Hati Salama has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Optimization of Controlled Human Malarial Infection by Injection of P. Falciparum Sporozoites in Non-Immune Adults [Phase 1]
A Phase 1 study by Sanaria Inc. to optimize controlled human malaria infection using Plasmodium falciparum sporozoites in non-immune adults …
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults [Phase 1]
Phase 1 trial by Sanaria investigates controlled human malaria infection via intravenous Plasmodium falciparum sporozoites in non-immune adu…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Home Based Child Care to Reduce Mortality and Malnutrition in Tribal Children of Melghat, India: CRCT [NA]
This document reports the completion of a cluster randomized trial evaluating home-based child care to reduce mortality and malnutrition amo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases and Malaria Antibody Kinetic
A completed clinical trial evaluating molecular markers of drug resistance in asymptomatic malaria cases and malaria antibody kinetics.
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns [Phase 3]
A Phase 3 study evaluating cardiac safety with repeated doses of dihydroartemisinin-piperaquine for mass malaria treatment campaigns has com…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: Safety and Immunogenicity of Direct Venous Inoculation of a Radiation-attenuated PfSPZ Vaccine in Equatoguinean Adults [Phase 1]
Phase 1 study evaluating the safety and immunogenicity of direct venous inoculation of a radiation-attenuated PfSPZ vaccine in Equatoguinean…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Efficacy,Safety and Tolerability of Dihydroartemisinin-Piperaquine for Uncomplicated Malaria in Pregnancy in Ghana [Phase 3]
Phase 3 clinical trial update assessing the efficacy, safety, and tolerability of dihydroartemisinin-piperaquine for uncomplicated malaria i…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Chemoprophylaxis and Plasmodium Falciparum NF54 Sporozoite Immunization Challenged by Heterologous Infection [NA]
A completed clinical trial evaluating chemoprophylaxis during Plasmodium falciparum NF54 sporozoite immunization challenged by heterologous …
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina Faso [Phase 1, Phase 2]
This is a completed Phase 1/2b trial evaluating an investigational malaria vaccination strategy in infants and children in Burkina Faso.
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM) [Phase 2, Phase 3]
Safety update from a Phase 2/3 trial evaluating primaquine plus artemether-lumefantrine in G6PD-deficient males with asymptomatic malaria. T…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Harmonized AS/MQ Efficacy Study - Thailand [Phase 4]
Phase 4 harmonized efficacy study of an artesunate-mefloquine combination for malaria conducted in Thailand has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Impact of a Parenting Program in Liberia to Improve Parenting, Education, and Health Outcomes for Children in Liberia [NA]
This completion notice reports a trial in Liberia evaluating a parenting program and its effects on parenting behaviors, children's pre-acad…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Dihydroartemisinin-piperaquine With Low Dose Primaquine to Reduce Malaria Transmission [Phase 3]
Phase 3 trial evaluating dihydroartemisinin-piperaquine with low-dose primaquine to reduce malaria transmission has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Bioavailability Study of Oral OZ439 Prototype Granule Formulations Administered With Piperaquine Phosphate (PQP) Tablets [Phase 1]
This Phase 1 bioavailability study evaluates oral OZ439 prototype granule formulations co-administered with Piperaquine phosphate tablets; r…
-
CLINICAL_TRIALS trial_result · 2016-01-08Clinical Trial Update: ICCM of Common Childhood Diseases: Mozambique and Uganda [NA]
A completed clinical trial update for ICCM of Common Childhood Diseases in Mozambique and Uganda, sponsored by Malaria Consortium, covering …
-
FDA approval · 2016-01-06FDA Approved: COARTEM — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for COARTEM (artemether and lumefantrine) from Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2015-12-22Clinical Trial Update: In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated P. Falciparum Malaria [Phase 4]
Phase 4 clinical trial assessing in vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falcipa…
-
CLINICAL_TRIALS research · 2015-12-21Clinical Trial Update: P. Falciparum Resistance to Artemisinin in Vietnam [Phase 4]
Phase 4 clinical trial update from Vietnam notes artemisinin resistance in Plasmodium falciparum malaria.
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Efficacy and Bio-availability of Artemether-Lumefantrine in Severely Malnourished Children [NA]
The completed trial evaluated the efficacy and bioavailability of artemether-lumefantrine in severely malnourished children with malaria.
-
FDA approval · 2015-12-17FDA Approved: QUININE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Quinine Sulfate from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: Innovative Public-private Partnership to Target Subsidized Antimalarials in the Retail Sector [NA]
Completed clinical trial update on a public-private partnership to target subsidized antimalarials in the retail sector.
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Evaluation of the Riamet® Versus Malarone® in the Treatment of Uncomplicated Malaria [Phase 4]
A Phase 4 trial completed comparing Riamet (artesunate-mefloquine) with Malarone (atovaquone-proguanil) for treating uncomplicated malaria.
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: An Extended Follow up of a RTS,S/AS01E Malaria Vaccine Trial
This document provides extended follow-up data from the RTS,S/AS01E malaria vaccine trial.